v3.26.1
Royalty Financing Agreement - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended
Oct. 31, 2022
Jun. 30, 2026
Dec. 31, 2025
Sep. 01, 2025
Debt Instrument [Line Items]        
Royalty financing liability   $ 37,774 $ 17,101  
Royalty Agreements        
Debt Instrument [Line Items]        
Royalty financing liability   $ 7,600 $ 6,400  
Royalty Agreements | Minimum        
Debt Instrument [Line Items]        
Royalty maximum 1.8      
Royalty Agreements | Maximum        
Debt Instrument [Line Items]        
Royalty maximum 1.9      
Royalty Agreements | ARIKAYCE Global Net Sales        
Debt Instrument [Line Items]        
Royalty percentage 4.00%     4.50%
Royalty Agreements | Brensocatib Global Net Sales        
Debt Instrument [Line Items]        
Royalty percentage 0.75%      
Secured Debt | Royalty Agreements        
Debt Instrument [Line Items]        
Proceeds from royalty financing $ 150,000      
Face amount 150,000      
Interest payments 150,000      
Lenders fees and deal expenses 3,800      
Proceeds from royalty financing agreement, net $ 146,200      
Effective interest rate 12.40%